Neuroinflammation is part of the complex immune response within the central nervous
system (CNS), whose details have been partially elucidated. The CNS immune response …

Due to an increasingly aging population, Alzheimer disease (AD) represents a crucial issue
for the healthcare system because of its widespread prevalence and the burden of its care …

This special issue of the International Journal of Alzheimer's disease contains a series of
cuttingedge articles that deal with the broad issue of inflammatory and immunological …

Alzheimer's disease (AD) is a devastative neurodegenerative disorder with complex
etiology. Neuroinflammation has been found to be an underlying cause of the disease …

After years of failed therapeutic attempts targeting beta-amyloid (Aβ) in AD, there is now
increasing evidence suggesting that inflammation holds a pivotal role in AD pathogenesis …

Alzheimer's disease (AD) is the most common neurodegenerative disorder to date. Next to
its classical histopathological characteristics such as deposition of fibrillogenic amyloid β …

New understanding in neuroscience has established that alongside the amyloid plaques,
neurofibrillary tangles and atrophy, the neuroinflammation triggered by the CNS's innate …

The incidence of dementia is increasing at an alarming rate, and has become a major public
health concern. Alzheimer disease (AD) is the most common form of dementia and is …

Alzheimer's disease (AD) is a serious brain disorder characterized by the presence of beta-
amyloid plaques, tau pathology, inflammation, neurodegeneration, and cerebrovascular …

Abstract The Alzheimer's Association's Research roundtable met in April 2015 to explore the
role of neuroinflammatory mechanisms in the progression of Alzheimer's disease (AD). The …